Luigi Meneghini

Professor

University of Texas Southwestern Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Luigi Meneghini is a Professor at The University of Texas Southwestern Medical Center in the United States. His research areas include diabetes care, risk factors for new-onset diabetes, and the impact of electronic health records on clinical practice. He has published recent articles focusing on topics such as the relationship between celiac disease and type 1 diabetes, as well as initiatives to improve diabetes care in urban health systems.

Articles (12)

Year:

2025

Year:

2025

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Ronald Goldberg

Professor

UNITED STATES

View details

Alberto Pugliese

Chair and Professor

Beckman Research Institute, City of Hope

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Luigi Meneghini

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Risk of new‐onset type 1 diabetes in individuals with celiac disease and thyroid disease—An observational study

Derivation and Validation of D-RISK: An Electronic Health Record–Driven Risk Score to Detect Undiagnosed Dysglycemia in Clinical Practice

Benefits of Electronic Consultations in Improving Diabetes Care Within a Safety-Net Health System

Decolonizing Care at Diagnosis: Culture, History, and Family at an Urban Inter‐tribal Clinic

Daniel H. Mintz (1930–2020): An Extraordinary Physician-Scientist and a Pioneer in Islet Transplantation

Lower-Extremity Amputation Trends Among People With Diabetes in a Large Urban Environment

Optimizing Glucose Meter Downloads at Parkland Diabetes Clinic

Impact of Quality Improvement (QI) Program on 5-Year Risk of Diabetes-Related Complications: A Simulation Study

A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of the ACHIEVE Control study

Insulin glargine 300 U/mL versus first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 12‐month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real‐life clinical trial

Design and Implementation of an Electronic Tool to Measure Medication Adherence at the Point of Care

Cover Image, Volume 22, Issue 11

Collaborators (2)

Ronald Goldberg

Alberto Pugliese

Make your next move.